Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 17 04:00PM ET
2.25
Dollar change
+0.24
Percentage change
11.94
%
Index- P/E- EPS (ttm)-1.89 Insider Own16.98% Shs Outstand50.48M Perf Week45.16%
Market Cap116.86M Forward P/E- EPS next Y-1.33 Insider Trans-0.15% Shs Float43.12M Perf Month65.44%
Income-92.61M PEG- EPS next Q-0.37 Inst Own41.67% Short Float3.30% Perf Quarter81.45%
Sales74.15M P/S1.58 EPS this Y37.18% Inst Trans-3.25% Short Ratio4.58 Perf Half Y36.36%
Book/sh2.35 P/B0.96 EPS next Y5.88% ROA-39.62% Short Interest1.42M Perf Year2.74%
Cash/sh1.84 P/C1.22 EPS next 5Y-13.70% ROE-58.92% 52W Range0.89 - 2.43 Perf YTD7.14%
Dividend Est.- P/FCF- EPS past 5Y-28.46% ROI-58.22% 52W High-7.41% Beta1.93
Dividend TTM- Quick Ratio3.56 Sales past 5Y18.20% Gross Margin25.59% 52W Low152.64% ATR (14)0.17
Dividend Ex-Date- Current Ratio3.72 EPS Y/Y TTM23.25% Oper. Margin-120.35% RSI (14)80.89 Volatility16.86% 10.22%
Employees225 Debt/Eq0.40 Sales Y/Y TTM7.96% Profit Margin-124.90% Recom1.33 Target Price4.60
Option/ShortYes / Yes LT Debt/Eq0.32 EPS Q/Q58.27% Payout- Rel Volume3.16 Prev Close2.01
Sales Surprise6.30% EPS Surprise36.07% Sales Q/Q3.53% EarningsMay 08 AMC Avg Volume310.97K Price2.25
SMA2062.78% SMA5059.40% SMA20059.97% Trades Volume952,709 Change11.94%
Date Action Analyst Rating Change Price Target Change
Feb-06-23Upgrade Needham Hold → Buy $8
Feb-06-23Upgrade Needham Hold → Buy
Jan-07-22Upgrade BofA Securities Neutral → Buy $27 → $23
Nov-05-21Downgrade Morgan Stanley Overweight → Equal-Weight
Nov-03-21Downgrade Needham Buy → Hold
Oct-15-21Resumed Cowen Outperform
Sep-20-21Reiterated Needham Buy $33 → $28
May-06-21Upgrade Oppenheimer Perform → Outperform $28
Jan-28-21Initiated Truist Buy $50
Jan-04-21Downgrade BofA Securities Buy → Neutral $40
Jul-11-24 09:00AM
Jun-18-24 04:01PM
Jun-13-24 08:00AM
Jun-04-24 04:05PM
May-31-24 09:05AM
09:05AM Loading…
May-22-24 09:05AM
May-17-24 04:05PM
May-09-24 12:31PM
07:11AM
04:00AM
May-08-24 08:59PM
04:22PM
04:01PM
Apr-24-24 04:01PM
Mar-28-24 04:01PM
09:00AM Loading…
09:00AM
Mar-26-24 09:00AM
Mar-19-24 04:43PM
Feb-29-24 09:44AM
Feb-28-24 05:00PM
04:01PM
Feb-14-24 04:01PM
Jan-31-24 04:01PM
Jan-30-24 09:00AM
Jan-17-24 04:15PM
Jan-16-24 09:05AM
Jan-05-24 09:05AM
Dec-04-23 09:15AM
Nov-28-23 04:15PM
Nov-16-23 04:05PM
03:03PM Loading…
03:03PM
Nov-08-23 01:45PM
Nov-07-23 04:50PM
04:01PM
Oct-26-23 08:15AM
Oct-24-23 04:01PM
Oct-21-23 04:25AM
Oct-19-23 07:15AM
Oct-18-23 07:15AM
Aug-29-23 04:01PM
Aug-24-23 07:01PM
Aug-15-23 10:20AM
Aug-08-23 05:40PM
04:32PM
04:01PM
Aug-01-23 04:01PM
Jul-25-23 04:01PM
Jul-13-23 06:51AM
Jun-26-23 05:00PM
Jun-13-23 07:01PM
Jun-08-23 10:49AM
May-30-23 08:00AM
May-16-23 08:00AM
May-07-23 03:07PM
May-05-23 12:03PM
May-04-23 01:03PM
May-03-23 05:45PM
04:37PM
04:01PM
May-02-23 08:00AM
Apr-19-23 04:01PM
Apr-08-23 08:10AM
Apr-05-23 04:01PM
08:45AM
Mar-22-23 08:55AM
Mar-07-23 08:55AM
Mar-02-23 04:05PM
Feb-28-23 12:00PM
Feb-26-23 07:31AM
Feb-24-23 01:32PM
Feb-23-23 04:01PM
Feb-09-23 04:01PM
Feb-07-23 10:07AM
Feb-06-23 04:01PM
01:41PM
Feb-03-23 12:38PM
08:45AM
Jan-19-23 10:17AM
04:31AM
Jan-05-23 05:21AM
Jan-04-23 04:01PM
Dec-16-22 04:05PM
Dec-14-22 04:02PM
Nov-30-22 08:55AM
Nov-21-22 04:01PM
Nov-07-22 04:05PM
02:16PM
Nov-02-22 05:15PM
04:01PM
Oct-31-22 04:16PM
Oct-19-22 04:01PM
Oct-11-22 01:45PM
Oct-04-22 09:00AM
Aug-30-22 04:01PM
Aug-17-22 04:15PM
Aug-16-22 04:05PM
Aug-15-22 08:55AM
Aug-08-22 12:26PM
Aug-04-22 04:01PM
Aug-03-22 05:35PM
Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tachibana AaronCFO AND COOJun 17 '24Sale1.297,1769,257176,012Jun 20 04:54 PM
Chen RichardCHIEF MEDICAL OFFICER AND EVPJun 17 '24Sale1.295,0556,521127,751Jun 20 04:55 PM
Moore Stephen MichaelSVP and Chief Legal OfficerJun 17 '24Sale1.291,5852,04569,081Jun 20 04:53 PM
Moore Stephen MichaelSVP and Chief Legal OfficerMay 17 '24Sale1.381,7312,38970,666May 21 09:11 PM
Tachibana AaronCFO AND COOMay 17 '24Sale1.381,3331,840183,188May 21 09:13 PM
Chen RichardCHIEF MEDICAL OFFICER AND EVPMay 17 '24Sale1.389401,297132,806May 21 09:14 PM
Moore Stephen MichaelSVP and Chief Legal OfficerApr 30 '24Sale1.374,5236,19772,397May 02 05:52 PM
MYERS WOODROW A JRDirectorMar 01 '24Buy1.6710,00016,70026,116Mar 05 05:15 PM
Tachibana AaronCFO AND COOJan 29 '24Sale1.37716981184,521Jan 31 04:27 PM
Chen RichardCHIEF MEDICAL OFFICER AND EVPJan 29 '24Sale1.37526721128,870Jan 31 04:30 PM
Tachibana AaronCFO and COODec 15 '23Sale1.476,7479,918185,237Dec 19 06:07 PM
Chen RichardChief Medical Officer and EVPDec 15 '23Sale1.474,7086,921129,396Dec 19 06:09 PM
Moore Stephen MichaelGeneral CounselDec 15 '23Sale1.471,4762,17076,920Dec 19 06:02 PM
Moore Stephen MichaelGeneral CounselNov 16 '23Sale1.041,7221,79178,396Nov 20 04:30 PM
Tachibana AaronCFO and COONov 16 '23Sale1.041,3441,398191,984Nov 20 04:30 PM
Chen RichardChief Medical Officer and EVPNov 16 '23Sale1.04940978124,104Nov 20 04:30 PM
Hall Christopher MPresident and CEONov 01 '23Sale0.9320,45919,027204,541Nov 03 09:00 PM
Tachibana AaronCFO and COOJul 31 '23Sale2.266621,496193,328Aug 02 04:21 PM
Chen RichardChief Medical Officer and EVPJul 31 '23Sale2.264851,096125,044Aug 02 04:20 PM